These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 15378224

  • 1. Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions.
    Micuda S, Mundlova L, Anzenbacherova E, Anzenbacher P, Chladek J, Fuksa L, Martinkova J.
    Eur J Clin Pharmacol; 2004 Oct; 60(8):583-9. PubMed ID: 15378224
    [Abstract] [Full Text] [Related]

  • 2. Potent inhibition of cytochrome P450 2B6 by sibutramine in human liver microsomes.
    Bae SH, Kwon MJ, Choi EJ, Zheng YF, Yoon KD, Liu KH, Bae SK.
    Chem Biol Interact; 2013 Sep 05; 205(1):11-9. PubMed ID: 23777987
    [Abstract] [Full Text] [Related]

  • 3. Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes.
    Guo Z, Raeissi S, White RB, Stevens JC.
    Drug Metab Dispos; 1997 Mar 05; 25(3):390-3. PubMed ID: 9172960
    [Abstract] [Full Text] [Related]

  • 4. Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions.
    Ohyama K, Nakajima M, Suzuki M, Shimada N, Yamazaki H, Yokoi T.
    Br J Clin Pharmacol; 2000 Mar 05; 49(3):244-53. PubMed ID: 10718780
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans.
    Mössner LD, Schmitz A, Theurillat R, Thormann W, Mevissen M.
    Am J Vet Res; 2011 Nov 05; 72(11):1505-13. PubMed ID: 22023129
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of cytochrome P450 enzymes and uridine 5'-diphospho-glucuronosyltransferases by vicagrel in human liver microsomes: A prediction of potential drug-drug interactions.
    Liu S, Wang Z, Chan E, Zhao Y, Kang J, Zhang X, Tian X.
    Chem Biol Interact; 2022 Jan 25; 352():109775. PubMed ID: 34910929
    [Abstract] [Full Text] [Related]

  • 11. Selective inhibition of cytochrome P450 2D6 by Sarpogrelate and its active metabolite, M-1, in human liver microsomes.
    Cho DY, Bae SH, Lee JK, Kim YW, Kim BT, Bae SK.
    Drug Metab Dispos; 2014 Jan 25; 42(1):33-9. PubMed ID: 24167220
    [Abstract] [Full Text] [Related]

  • 12. Enantiospecific effects of chiral drugs on cytochrome P450 inhibition in vitro.
    Krasulova K, Siller M, Holas O, Dvorak Z, Anzenbacher P.
    Xenobiotica; 2016 Jan 25; 46(4):315-24. PubMed ID: 26338061
    [Abstract] [Full Text] [Related]

  • 13. In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions.
    Wójcikowski J, Danek PJ, Basińska-Ziobroń A, Pukło R, Daniel WA.
    Pharmacol Rep; 2020 Jun 25; 72(3):612-621. PubMed ID: 32219694
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vitro evaluation of the inhibition and induction potential of olaparib, a potent poly(ADP-ribose) polymerase inhibitor, on cytochrome P450.
    McCormick A, Swaisland H, Reddy VP, Learoyd M, Scarfe G.
    Xenobiotica; 2018 Jun 25; 48(6):555-564. PubMed ID: 28657402
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory Effects of Dimethyllirioresinol, Epimagnolin A, Eudesmin, Fargesin, and Magnolin on Cytochrome P450 Enzyme Activities in Human Liver Microsomes.
    Kim JH, Kwon SS, Jeong HU, Lee HS.
    Int J Mol Sci; 2017 May 01; 18(5):. PubMed ID: 28468305
    [Abstract] [Full Text] [Related]

  • 17. Interaction of buprenorphine and its metabolite norbuprenorphine with cytochromes p450 in vitro.
    Zhang W, Ramamoorthy Y, Tyndale RF, Sellers EM.
    Drug Metab Dispos; 2003 Jun 01; 31(6):768-72. PubMed ID: 12756210
    [Abstract] [Full Text] [Related]

  • 18. In vitro characterization of sarizotan metabolism: hepatic clearance, identification and characterization of metabolites, drug-metabolizing enzyme identification, and evaluation of cytochrome p450 inhibition.
    Gallemann D, Wimmer E, Höfer CC, Freisleben A, Fluck M, Ladstetter B, Dolgos H.
    Drug Metab Dispos; 2010 Jun 01; 38(6):905-16. PubMed ID: 20219851
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro.
    Zhang W, Kilicarslan T, Tyndale RF, Sellers EM.
    Drug Metab Dispos; 2001 Jun 01; 29(6):897-902. PubMed ID: 11353760
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions.
    Katoh M, Nakajima M, Shimada N, Yamazaki H, Yokoi T.
    Eur J Clin Pharmacol; 2000 Jun 01; 55(11-12):843-52. PubMed ID: 10805063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.